Conquer Cancer announces 2022 ASCO Annual Meeting Merit Award Recipients

Vicki Kilpatrick
Merit Award Recipients

ALEXANDRIA, Va. – Conquer Cancer®, the ASCO Foundation, is pleased to announce the recipients of its 2022 ASCO Annual Meeting Merit Awards. 

Annual Meeting Merit Awards support oncology trainees who are first authors on abstracts selected for presentation at the ASCO Annual Meeting. This year, Conquer Cancer will recognize 151 recipients with Merit Awards. These oncology professionals are recognized for their respective field and research advancements within the cancer care community.   

The 2022 ASCO Annual Meeting Merit Award Recipients are: 

View all Merit Award recipients.

Special Merit Awards are presented each year to trainees and junior faculty who have the top-ranking abstracts for the ASCO Annual Meeting. The ASCO Scientific Program Committee will present five recipients with Special Merit Awards in their respective abstract categories.  

The 2022 Special Merit Award recipients are:  

William Chen, MD, University of California, San Francisco 

  • Receives the Bradley Stuart Beller Endowed Merit Award    
  • Supported by the Friends and Family of Dr. and Mrs. Ronald Beller  

Justin Barnes, MD, MS, Washington University School of Medicine 

  • Receives the Allen S. Lichter, MD, Endowed Merit Award    

Chalita Lagampan, MD, Chulalongkorn University 

  • Receives the Pain and Symptom Management Special Merit Award    

Puja Umaretiya, MD, Dana-Farber Cancer Institute and Boston Children's Cancer and Blood Disorders Center 

  • Receives the Brigid Leventhal Special Merit Award    
  • Supported by The Berry Family In honor of Jake Berry   

Thai Hoa Tran, MD, CHU Ste-Justine, University of Montreal 

  • Receives the James B. Nachman Endowed ASCO Junior Faculty Award in Pediatric Oncology  
  • Supported by Friends and Family of Dr. James B. Nachman 


The 2022 Conquer Cancer Merit Awards are sponsored by:  

Anonymous, ASCO Employees, Association of Northern California Oncologists, AstraZeneca, BeiGene, Friends and Family of Dr. and Mrs. Ronald Beller, Dr. and Mrs. Douglas W. Blayney, Breast Cancer Research Foundation®, Bristol Myers Squibb, Jonathan K. and Cora Y. Cho Charitable Fund, Friends, Family, and Colleagues of Dr. Cecil "Pete" Coggins, Michael Craig Cox, PharmD, MHS, BCOP, Trailblazing patient Mark A. Crafts and Generous Supporters of Team Crafty, Bill and Karen Dahut, Eisai Inc., Estate of Darla C. Ellis, Epiphany Partners Inc., Flatiron Health, Inc., G1 Therapeutics, GlaxoSmithKline Oncology, Harborside, Friends, Colleagues, and Family of Joe Hogan, Ipsen Biopharmaceuticals Inc., Kimberly Irvine, Michael Kelley, MD & Elise Hoffman, PharmD, Nicole M. Kuderer, MD and Gary H. Lyman, MD, MPH, FASCO, Natasha B. Leighl, MD, FASCO, William T. Leslie, MD, Lilly, Loxo Oncology Inc., a wholly owned subsidiary of Eli Lilly and Company, Maryland/DC Society of Clinical Oncology, Therese Marie Mulvey, MD, FASCO, Friends and Family of Dr. James B. Nachman, New Rhein Healthcare, LLC, Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc, Dr. Kathleen Pritchard Medicine Professional Corporation, Doreen J. Putrah Cancer Research Foundation, The QuadW Foundation, Sarah Cannon Research Institute, Frances A. Shepherd, MD, FASCO, Stephen A. Sherwin, MD, Drs. Rachna and Puneet Shroff, Supporters of Innovations and Research in Medical Education, Syndax Pharmaceuticals, Inc., Nizar M. Tannir, MD, Anthony and Marilyn Tolcher, and Dr. Michael and Deborah Troner.